Researchers at the University of Nottingham’s Brain Tumour Research Centre of Excellence have developed a rapid diagnostic test that significantly reduces the time needed to diagnose brain tumours. The new test allows for identification of certain types of brain cancer during surgery, shortening the typical diagnostic process from several weeks to just a few hours.

Currently, patients often wait up to eight weeks for confirmation of a brain tumour diagnosis after surgery, as tissue samples require extensive laboratory analysis. The new technique, however, enables medical teams to receive results while the patient remains on the operating table, potentially allowing surgeons to make more informed decisions during the procedure.

Frankie Swords, NHS medical director, described the advancement as “a huge leap forward for patients,” highlighting the benefits of quicker diagnosis in improving treatment planning and patient outcomes. By providing near-immediate diagnostic information, the test may also help alleviate the stress and uncertainty patients face during prolonged waiting periods.

The development represents a significant step forward in brain cancer care, opening possibilities for more personalized and timely interventions. Ongoing research will focus on validating the test across different tumour types and clinical settings to expand its utility.